Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma()

door Geoerger, Birgit, Kieran, Mark W., Grupp, Stephan, Perek, Danuta, Clancy, Jill, Krygowski, Mizue, Ananthakrishnan, Revathi, Boni, Joseph P., Berkenblit, Anna, Spunt, Sheri L.
Gepubliceerd in 2011

Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors

door Spunt, Sheri L., Grupp, Stephan A., Vik, Terry A., Santana, Victor M., Greenblatt, David J., Clancy, Jill, Berkenblit, Anna, Krygowski, Mizue, Ananthakrishnan, Revathi, Boni, Joseph P., Gilbertson, Richard J.
Gepubliceerd in 2011

Lorlatinib in ALK- or ROS1-rearranged non-small cell lung cancer: an international, multicenter, open-label phase 1 trial

door Shaw, Alice T., Felip, Enriqueta, Bauer, Todd M., Besse, Benjamin, Navarro, Alejandro, Postel-Vinay, Sophie, Gainor, Justin F., Johnson, Melissa, Dietrich, Jorg, James, Leonard P., Clancy, Jill S., Chen, Joseph, Martini, Jean-François, Abbattista, Antonello, Solomon, Benjamin J.
Gepubliceerd in Lancet Oncol (2017)

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

door Shaw, Alice T., Solomon, Benjamin J., Besse, Benjamin, Bauer, Todd M., Lin, Chia-Chi, Soo, Ross A., Riely, Gregory J., Ou, Sai-Hong Ignatius, Clancy, Jill S., Li, Sherry, Abbattista, Antonello, Thurm, Holger, Satouchi, Miyako, Camidge, D. Ross, Kao, Steven, Chiari, Rita, Gadgeel, Shirish M., Felip, Enriqueta, Martini, Jean-François
Gepubliceerd in J Clin Oncol (2019)